• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水果格兰诺拉麦片(Frugra®)摄入对血液透析患者血压降低和肠道微生物群的影响。

Effect of fruits granola (Frugra®) consumption on blood pressure reduction and intestinal microbiome in patients undergoing hemodialysis.

机构信息

Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan.

Division of Nephrology, Department of Internal Medicine, Juntendo University Shizuoka Hospital, Shizuoka, Japan.

出版信息

Hypertens Res. 2024 Nov;47(11):3214-3224. doi: 10.1038/s41440-024-01895-1. Epub 2024 Sep 19.

DOI:10.1038/s41440-024-01895-1
PMID:39300301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11534689/
Abstract

Cardiovascular diseases (CVDs) are a major cause of death in patients undergoing hemodialysis (HD). Blood pressure (BP) and uremic toxins are well-known risk factors for CVDs, which are influenced by diet. Dietary fiber supplementation in patients undergoing HD may reduce the risk of CVDs by improving lipid profiles and inflammatory status and lowering the levels of the uremic toxin indoxyl sulfate (IS). In this study, we investigated the relationship between the intestinal microbiota and risk factors for CVDs, such as BP and serum IS, in patients undergoing HD who consumed fruits granola (FGR). The study participants were selected from patients undergoing HD at the Izu Nagaoka Daiichi Clinic and consumed FGR for 2 months. Body composition and blood samples were tested at months 0, 1, 2 and fecal samples were collected at months 0 and 2 for intestinal microbiota analysis. FGR consumption decreased systolic and diastolic BP, estimated salt intake, and serum IS levels and improved the stool characteristics according to the Bristol Stool Form Scale (N = 24). Gut microbiota analysis showed an increase in the alpha diversity and abundance of Blautia and Neglecta. The abundance of lactic acid- and ethanol-producing bacteria also significantly increased, whereas the abundance of indole-producing bacteria significantly decreased. FGR consumption could be a useful tool for salt reduction, fiber supplementation, and improvement of the intestinal environment, thus contributing to improvement of BP and the reduction of other risk factors for CVDs in patients undergoing HD.

摘要

心血管疾病 (CVDs) 是接受血液透析 (HD) 治疗的患者死亡的主要原因。血压 (BP) 和尿毒症毒素是 CVDs 的已知危险因素,它们受饮食影响。接受 HD 治疗的患者补充膳食纤维可能通过改善血脂谱和炎症状态以及降低尿毒症毒素吲哚硫酸酯 (IS) 的水平来降低 CVDs 的风险。在这项研究中,我们研究了肠道微生物群与 CVDs 的危险因素(如 BP 和血清 IS)之间的关系,这些患者接受 HD 治疗并食用水果格兰诺拉麦片 (FGR)。研究参与者选自在伊豆长冈第一诊所接受 HD 治疗的患者,并食用 FGR 达 2 个月。在 0 个月、1 个月、2 个月时测试身体成分和血液样本,并在 0 个月和 2 个月时采集粪便样本进行肠道微生物群分析。FGR 的摄入降低了收缩压和舒张压、估计盐摄入量以及血清 IS 水平,并根据布里斯托粪便形态量表改善了粪便特征 (N = 24)。肠道微生物群分析显示 α多样性和 Blautia 和 Neglecta 的丰度增加。产乳酸和乙醇的细菌的丰度也显著增加,而吲哚产生菌的丰度显著降低。FGR 的摄入可能是减少盐、补充纤维和改善肠道环境的有用工具,从而有助于改善 HD 患者的血压和降低 CVDs 的其他危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67fe/11534689/4ef2b17bfb42/41440_2024_1895_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67fe/11534689/6888778e838d/41440_2024_1895_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67fe/11534689/69d9bb7fe7d1/41440_2024_1895_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67fe/11534689/4ef2b17bfb42/41440_2024_1895_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67fe/11534689/6888778e838d/41440_2024_1895_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67fe/11534689/69d9bb7fe7d1/41440_2024_1895_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67fe/11534689/4ef2b17bfb42/41440_2024_1895_Fig3_HTML.jpg

相似文献

1
Effect of fruits granola (Frugra®) consumption on blood pressure reduction and intestinal microbiome in patients undergoing hemodialysis.水果格兰诺拉麦片(Frugra®)摄入对血液透析患者血压降低和肠道微生物群的影响。
Hypertens Res. 2024 Nov;47(11):3214-3224. doi: 10.1038/s41440-024-01895-1. Epub 2024 Sep 19.
2
Safety and efficacy of using cereal food (Frugra®) to improve blood pressure and bowel health in patients undergoing chronic hemodialysis: A pilot study.在接受慢性血液透析的患者中使用谷物食品(Frugra®)改善血压和肠道健康的安全性和有效性:一项初步研究。
J Pharmacol Sci. 2021 Sep;147(1):132-137. doi: 10.1016/j.jphs.2021.06.007. Epub 2021 Jun 18.
3
Effects of Propolis Supplementation on Gut Microbiota and Uremic Toxin Profiles of Patients Undergoing Hemodialysis.蜂胶补充对接受血液透析患者肠道微生物群和尿毒症毒素谱的影响。
Toxins (Basel). 2024 Sep 25;16(10):416. doi: 10.3390/toxins16100416.
4
Effect of Dietary Inulin Supplementation on the Gut Microbiota Composition and Derived Metabolites of Individuals Undergoing Hemodialysis: A Pilot Study.膳食菊粉补充对血液透析个体肠道微生物组组成和衍生代谢物的影响:一项初步研究。
J Ren Nutr. 2021 Sep;31(5):512-522. doi: 10.1053/j.jrn.2020.10.003. Epub 2021 Jun 11.
5
Associations Among Plant-Based Diet Quality, Uremic Toxins, and Gut Microbiota Profile in Adults Undergoing Hemodialysis Therapy.植物性饮食质量、尿毒症毒素与行血液透析治疗的成年人肠道微生物组特征的关联。
J Ren Nutr. 2021 Mar;31(2):177-188. doi: 10.1053/j.jrn.2020.07.008. Epub 2020 Sep 25.
6
Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study.儿科终末期肾病患者的肠道微生物群:中西部儿科肾脏病联盟的研究。
Microbiome. 2016 Sep 17;4(1):50. doi: 10.1186/s40168-016-0195-9.
7
High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice.高纤维饮食和乙酸盐补充改变肠道微生物群,预防高血压小鼠高血压和心力衰竭的发生。
Circulation. 2017 Mar 7;135(10):964-977. doi: 10.1161/CIRCULATIONAHA.116.024545. Epub 2016 Dec 7.
8
Gut Microbiome and Microbiome-Derived Metabolites in Patients with End-Stage Kidney Disease.终末期肾病患者的肠道微生物组和微生物组衍生代谢物。
Int J Mol Sci. 2023 Jul 14;24(14):11456. doi: 10.3390/ijms241411456.
9
Effect of sucroferric oxyhydroxide on gastrointestinal microbiome and uremic toxins in patients with chronic kidney disease undergoing hemodialysis.蔗糖铁氧羟化物对血液透析慢性肾脏病患者胃肠道微生物组和尿毒症毒素的影响。
Clin Exp Nephrol. 2020 Aug;24(8):725-733. doi: 10.1007/s10157-020-01892-x. Epub 2020 Apr 13.
10
Associations among total p-cresylsulfate, indoxyl sulfate and hippuric acid levels with hemodialysis quality indicators in maintenance hemodialysis patients.维持性血液透析患者中对甲酚硫酸酯总量、硫酸吲哚酚和马尿酸水平与血液透析质量指标之间的关联。
Clin Chim Acta. 2021 May;516:83-91. doi: 10.1016/j.cca.2021.01.015. Epub 2021 Jan 26.

引用本文的文献

1
Effectiveness of personalized granola tailored to the gut microbiota for improving gut environment and mood states.根据肠道微生物群定制的个性化燕麦片对改善肠道环境和情绪状态的有效性。
Front Microbiol. 2025 Jul 25;16:1607918. doi: 10.3389/fmicb.2025.1607918. eCollection 2025.
2
Evaluation of the Fermentation Characteristics of Prebiotic-Containing Granola and Short-Chain Fatty Acid Production in an In Vitro Gut Microbiota Model.在体外肠道微生物群模型中对含益生元的格兰诺拉麦片的发酵特性和短链脂肪酸产生的评估。
Food Sci Nutr. 2025 May 7;13(5):e70252. doi: 10.1002/fsn3.70252. eCollection 2025 May.
3
Granola consumption with multiple prebiotics in Japanese participants increases abundance and improves stress and subjective sleepiness.

本文引用的文献

1
Perspectives on the involvement of the gut microbiota in salt-sensitive hypertension.肠道微生物群在盐敏感性高血压中的作用的观点。
Hypertens Res. 2024 Sep;47(9):2351-2362. doi: 10.1038/s41440-024-01747-y. Epub 2024 Jun 14.
2
Research Progress on the Correlation Between Hypertension and Gut Microbiota.高血压与肠道微生物群相关性的研究进展
J Multidiscip Healthc. 2024 May 16;17:2371-2387. doi: 10.2147/JMDH.S463880. eCollection 2024.
3
The differential effect of two cereal foods on gut environment: a randomized, controlled, double-blind, parallel-group study.
在日本参与者中,食用含有多种益生元的格兰诺拉麦片可增加有益菌数量,并改善压力和主观困倦感。
Front Nutr. 2025 Mar 20;12:1551313. doi: 10.3389/fnut.2025.1551313. eCollection 2025.
两种谷物食品对肠道环境的差异影响:一项随机、对照、双盲、平行组研究。
Front Nutr. 2024 Feb 22;10:1254712. doi: 10.3389/fnut.2023.1254712. eCollection 2023.
4
Recent Advances in Understanding Peripheral and Gut Immune Cell-Mediated Salt-Sensitive Hypertension and Nephropathy.外周和肠道免疫细胞介导的盐敏感性高血压和肾病的研究进展。
Hypertension. 2024 Mar;81(3):436-446. doi: 10.1161/HYPERTENSIONAHA.123.22031. Epub 2024 Jan 2.
5
Lactic acid bacteria in relieving constipation: mechanism, clinical application, challenge, and opportunity.乳酸菌在缓解便秘中的作用:机制、临床应用、挑战与机遇
Crit Rev Food Sci Nutr. 2025;65(3):551-574. doi: 10.1080/10408398.2023.2278155. Epub 2023 Nov 16.
6
Gut microbiota changes in patients with hypertension: A systematic review and meta-analysis.高血压患者肠道菌群变化的系统评价和荟萃分析。
J Clin Hypertens (Greenwich). 2023 Dec;25(12):1053-1068. doi: 10.1111/jch.14722. Epub 2023 Oct 18.
7
Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality.全球可改变风险因素对心血管疾病和死亡的影响。
N Engl J Med. 2023 Oct 5;389(14):1273-1285. doi: 10.1056/NEJMoa2206916. Epub 2023 Aug 26.
8
Diagnosis of cardiovascular disease in patients with chronic kidney disease.慢性肾脏病患者心血管疾病的诊断
Nat Rev Nephrol. 2023 Nov;19(11):733-746. doi: 10.1038/s41581-023-00747-4. Epub 2023 Aug 23.
9
Characteristics of Intestinal Microbiota in Japanese Patients with Mild Cognitive Impairment and a Risk-Estimating Method for the Disorder.日本轻度认知障碍患者肠道微生物群的特征及该疾病的风险评估方法
Biomedicines. 2023 Jun 22;11(7):1789. doi: 10.3390/biomedicines11071789.
10
Mechanisms of Oxidative Stress in Metabolic Syndrome.代谢综合征中的氧化应激机制。
Int J Mol Sci. 2023 Apr 26;24(9):7898. doi: 10.3390/ijms24097898.